Cholesterol

Cholesterol

SCHEMBL27776979

CC(C)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.CCCCCCCC/C=C/CCCCCCCC(=O)O

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ OSBP P22059 3/20 0.73
▸ RORC P51449 3/20 0.73
▸ USP2 O75604 1/20 0.73
▸ LMNA P02545 1/20 0.73
▸ ABCB1 P08183 1/20 0.73
▸ OSBP2 Q969R2 1/20 0.73
▸ CYP46A1 Q9Y6A2 1/20 0.73
▸ NR1H3 Q13133 6/20 0.71
▸ EPHA2 P29317 1/20 0.71
▸ GRIN1 Q05586 1/20 0.63
▸ GRIN2A Q12879 1/20 0.63
▸ NPC1L1 Q9UHC9 2/20 0.63
▸ POLA1 P09884 1/20 0.62
▸ DHCR24 Q15392 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cholesterol SCHEMBL150062 1.00 OSBP (0.73) OSBPRORCUSP2LMNAABCB1
Cholesterol SCHEMBL4786128 1.00 OSBP (0.73) OSBPRORCUSP2LMNAABCB1
Cholesterol SCHEMBL27962121 1.00 OSBP (0.73) OSBPRORCUSP2LMNAABCB1
Cholesterol SCHEMBL29729264 1.00 OSBP (0.73) OSBPRORCUSP2LMNAABCB1
Cholesterol SCHEMBL28637815 1.00 OSBP (0.73) OSBPRORCUSP2LMNAABCB1
Cholesterol SCHEMBL28494148 0.99 OSBP (0.72) OSBPRORCUSP2LMNAABCB1
Cholesterol SCHEMBL27761732 0.98 OSBP (0.71) OSBPRORCUSP2LMNAABCB1
Cholesterol SCHEMBL3267892 0.98 OSBP (0.71) OSBPRORCUSP2LMNAABCB1
Cholesterol SCHEMBL3267895 0.98 OSBP (0.71) OSBPRORCUSP2LMNAABCB1
Cholesterol SCHEMBL28929518 0.98 OSBP (0.73) OSBPRORCUSP2LMNAABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108024957-B Compositions and methods for nanoparticle lyophilisate form 日东电工株式会社 2021-08-24 — — CN disclosed
CN-111386105-A Membrane fusion compounds for delivery of bioactive molecules 日东电工株式会社 2020-07-07 — — CN disclosed
CN-111214701-A Implants for localized drug delivery and methods of use thereof 加利福尼亚大学董事会 2020-06-02 — — CN disclosed
CN-106573133-B Implants for localized drug delivery and methods of use thereof 加利福尼亚大学董事会 2020-03-03 — — CN disclosed
CN-108096192-A Proliposome testosterone preparation 健康科学西部大学 2018-06-01 — — CN disclosed
CN-104780914-B Proliposomal testosterone formulations 健康科学西部大学 2018-02-09 — — CN disclosed
CN-104780914-A Proliposomal testosterone formulations UNIV WESTERN HEALTH SCIENCES 2015-07-15 — — CN disclosed
CN-104382853-A Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics MARINA BIOTECH INC 2015-03-04 — — CN disclosed
CN-102231979-B Liposome efficient delivery methods and compositions for gene silencing therapeutics MARINA BIOTECH, INC. (US) 2014-10-29 — — CN disclosed
CN-101674853-B Amino acid lipids and uses thereof NASTECH PHARM CO 2013-03-27 — — CN disclosed
CN-102231979-A Liposome efficient delivery methods and compositions for gene silencing therapeutics MDRNA INC 2011-11-02 — — CN disclosed
CN-101674853-A Amino acid lipids and uses thereof NASTECH PHARM CO 2010-03-17 — — CN disclosed
Send feedback